Literature DB >> 20084488

Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves.

J C Hurley1.   

Abstract

The limulus assay for endotoxin has been studied as a method for the rapid identification of gram-negative (GN) bacteraemia. The chromogenic (C-limulus) version is 100-fold more sensitive to an internal endotoxin standard than the earlier gelation version (G-limulus). The objective of this analysis is to compare the concordance between GN bacteraemia and endotoxaemia as determined in clinical studies using either version of the limulus assay. The summary results for the diagnostic odds ratio (DOR), sensitivity and specificity were derived using a hierarchical summary receiver operating characteristic (HSROC) method of meta-analysis. Fifty-eight studies (25 G-limulus and 33 C-limulus) were included. Surprisingly, the mean DOR (4.9; 3-7.9 versus 10.7; 5.2-21.8) was inferior for studies using the C-limulus versus the original G-limulus version of the assay. Moreover, among studies limited to sepsis syndrome patients, the mean DOR remains poor at 4.2 (1.8-9.5). The proportion of GN bacteraemic patients for whom endotoxaemia is not detectable with either version of the limulus assay is >20% among the 58 studies overall, but >30% after the exclusion of studies with <25 patients and >20% among studies of patients with sepsis syndrome. These findings help to reconcile seemingly disparate study results.

Entities:  

Mesh:

Year:  2009        PMID: 20084488     DOI: 10.1007/s10096-009-0841-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  76 in total

1.  Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality.

Authors:  P van Langevelde; K Joop; J van Loon; M Frölich; P H Groeneveld; R G Westendorp; J T van Dissel
Journal:  Clin Infect Dis       Date:  2000-11-29       Impact factor: 9.079

Review 2.  Septic shock: pathogenesis.

Authors:  M P Glauser; G Zanetti; J D Baumgartner; J Cohen
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

3.  Clinical experience on the detection of endotoxemia with the limulus test.

Authors:  L A Martinez; R Quintiliani; R C Tilton
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

4.  Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies.

Authors:  M Yoshida; T Obayashi; H Tamura; S Tanaka; T Kawai; S Sakamoto; Y Miura
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

5.  Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.

Authors:  R L Danner; C Natanson; R J Elin; J M Hosseini; S Banks; T J MacVittie; J E Parrillo
Journal:  Chest       Date:  1990-12       Impact factor: 9.410

6.  The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis.

Authors:  G R Jones; J A Lowes
Journal:  QJM       Date:  1996-07

7.  Hemolytic-uremic syndrome: absence of circulating endotoxin.

Authors:  P M van Wieringen; L A Monnens; J A Bakkeren
Journal:  Pediatrics       Date:  1976-10       Impact factor: 7.124

8.  Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit.

Authors:  B Guidet; V Barakett; T Vassal; J C Petit; G Offenstadt
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

9.  Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.

Authors:  C Natanson; R L Danner; R J Elin; J M Hosseini; K W Peart; S M Banks; T J MacVittie; R I Walker; J E Parrillo
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

10.  Endotoxemia in protein-energy malnutrition.

Authors:  K Klein; G J Fuchs; P Kulapongs; G Mertz; R M Suskind; R E Olson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

View more
  7 in total

1.  Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by gram-negative organisms: a meta-analysis of 4 decades of studies.

Authors:  James C Hurley; Piotr Nowak; Lars Öhrmalm; Charalambos Gogos; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

Review 2.  Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders.

Authors:  James C Hurley; Bertrand Guidet; Georges Offenstadt; Eric Maury
Journal:  Crit Care       Date:  2012-08-07       Impact factor: 9.097

Review 3.  Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.

Authors:  James C Hurley
Journal:  Toxins (Basel)       Date:  2013-12-18       Impact factor: 4.546

4.  Maternal LPS exposure during pregnancy impairs testicular development, steroidogenesis and spermatogenesis in male offspring.

Authors:  Hua Wang; Lu-Lu Yang; Yong-Fang Hu; Bi-Wei Wang; Yin-Yin Huang; Cheng Zhang; Yuan-Hua Chen; De-Xiang Xu
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

5.  Comparative Study of Plasma Endotoxin with Procalcitonin Levels in Diagnosis of Bacteremia in Intensive Care Unit Patients.

Authors:  Tao Wang; Yun-Liang Cui; Zhao-Fen Lin; De-Chang Chen
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

6.  Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia.

Authors:  Michelle Wong; Babilonia Barqasho; Lars Ohrmalm; Thomas Tolfvenstam; Piotr Nowak
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

Review 7.  Could simulation methods solve the curse of sparse data within clinical studies of antibiotic resistance?

Authors:  James C Hurley; David Brownridge
Journal:  JAC Antimicrob Resist       Date:  2021-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.